within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J05A_DirectActingAntivirals.J05AG01_Nevirapine;

model Nevirapine
  extends Pharmacolibrary.Drugs.ATC.J.J05AG01;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>J05AG01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Nevirapine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used in the treatment of human immunodeficiency virus (HIV)-1 infection. It is typically used in combination with other antiretroviral agents. Nevirapine is approved for use in adults and children and is available in oral tablet and suspension formulations.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adult volunteers; oral administration of 200 mg nevirapine twice daily.</p><h4>References</h4><ol><li><p>Podany, AT, et al., &amp; Fletcher, CV (2021). Nevirapine pharmacokinetics in HIV-infected persons receiving rifapentine and isoniazid for TB prevention. <i>The Journal of antimicrobial chemotherapy</i> 76(3) 718–721. DOI:<a href=&quot;https://doi.org/10.1093/jac/dkaa470&quot;>10.1093/jac/dkaa470</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33241266/&quot;>https://pubmed.ncbi.nlm.nih.gov/33241266</a></p></li><li><p>Foster, RH, &amp; Faulds, D (1998). Abacavir. <i>Drugs</i> 55(5) 729–738. DOI:<a href=&quot;https://doi.org/10.2165/00003495-199855050-00018&quot;>10.2165/00003495-199855050-00018</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9585869/&quot;>https://pubmed.ncbi.nlm.nih.gov/9585869</a></p></li><li><p>Dailly, E, et al., &amp; Raffi, F (2015). Influence of nevirapine administration on the pharmacokinetics of dolutegravir in patients infected with HIV-1. <i>The Journal of antimicrobial chemotherapy</i> 70(12) 3307–3310. DOI:<a href=&quot;https://doi.org/10.1093/jac/dkv245&quot;>10.1093/jac/dkv245</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/26271944/&quot;>https://pubmed.ncbi.nlm.nih.gov/26271944</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Nevirapine;
